SLV320: Clinical Trials

3 trials of SLV320, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow SLV320: new trials by email Literature Review of SLV320 trials Research Report on SLV320

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure
SLV320, Placebo - Acute Decompensated Heart Failure; Renal Dysfunction
Phase 2TerminatedSolvay Pharmaceuticals462009-02-012010-09-17
Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function
SLV320 - Congestive Heart Failure
TerminatedSolvay Pharmaceuticals3002007-10-012008-04-22
Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure
SLV320 - Congestive Heart Failure
Phase 2CompletedSolvay Pharmaceuticals2005-01-012009-01-30

Conditions studied

Heart Failure (2)  ·  Renal Insufficiency (2)

Sponsors

Solvay Pharmaceuticals (3)

Countries

Germany (3)  ·  Poland (2)  ·  Russia (2)  ·  United States (2)  ·  Argentina (1)  ·  Belgium (1)  ·  Canada (1)  ·  Chile (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Italy (1)  ·  Romania (1)  ·  Serbia and Montenegro (1)  ·  South Africa (1)

Top investigators

Robyn Bethany (1)

Results publications

PMID 19919976, PMID 21641345

NIH funding

2004 (1), 2008 (1)